Searched for
PFIZER ONCOLOGY PRODUCTS
Johnson & Johnson prostate cancer drug reduces risk of cancer spread and death in late-stage studyThe study, which followed patients for over five years, found that those who received the regimen were nine times more likely to have lit...- From oncology to obesity, Pfizer bets big on India for its next growth wavePfizer is prioritizing India for future growth. The company plans to launch new medicines here soon after their global release. Pfizer aims...
- Chinese medicines bring relief to India’s cancer patientsIndia’s cancer treatment landscape is seeing a shift as lower-cost immunotherapy drugs developed in China and marketed through Indian partn...
- US market today: Pfizer posts strong first-quarter, sees boost from recent legal winsPfizer reported higher-than-expected sales and profit on Tuesday and said a patent extension for its Vyndamax heart drug and a recent favor...
- Samsung Biologics unveils $897 mln manufacturing deals for PfizerSouth Korea's Samsung Biologics announced on Tuesday two deals with Pfizer worth a combined $897 million to manufacture products for the U....
- Pfizer buys Seagen for $43B, boosts access to cancer drugsThe deal announced Monday will combine Seagen's technology with Pfizer's scale and strength, Pfizer CEO Albert Bourla said in a statement. ...
- Pfizer to back startups in India working on oncology, digital healthPfizer will provide grants of up to Rs 65 lakh and two years of incubation support through the Indian Institutes of Technology (IITs) and o...
- Merck KGaA bets on cancer drugs to revitalise German firmMerck KGaA is betting on its oncology pipeline to revitalise the German drugmaker as it sees falling sales from its best-selling medicine, ...
- German drug maker Merck KGaA finds Indian market promising for its pharma, consumer health businessMerck KGaA, the family-controlled $12.5-billion German drug maker, has identified India as one of its key markets under aglobal expansion s...
- Pfizer to internally split its generic, branded drugs operationsPharma giant Pfizer Inc today said it plans to internally separate operations into three segments.
- Will continue selling Nexavar drug post IPAB verdict: Bhaskar Narayana, Natco PharmaIn an interview with ET Now, Bhaskar Narayana, Finance-Director, Natco Pharma, talks about the IPAB’s verdict on Natco’s cancer drug case a...
- Biocon Ltd gives Malaysian company CCM Pharmaceuticals licence for insulin distributionAccording to CCM, Malaysia’s anti-diabetic market is growing at 10.6 per cent annually. In 2011, it was worth RM 277 million.
- Strides Arcolab gets USFDA approval for generic cancer drugCiting IMS data, Strides Arcolab said the US market for generic Ifosfamide is approximately $15 million.
- Strides Arcolab hits 52-week high on US FDA approval for Ifosfamide injectionStrides Arcolab Ltd surged over 2 per cent in trade on Thursday after Onco Therapies received ANDA approval for Ifosfamide Injection.
- Strides Arcolab gets USFDA nod for cancer drugStrides Arcolab said its subsidiary has received USFDA American health regulator's approval to sell Vinorelbine injection, a cancer drug, i...
- Pfizer looking for Indian cos to partner in treating cancer patientsPfizer has identified oncology as the therapeutic segment for research in emerging markets such as China and India as cancer is one of the ...
- Strides Arcolab gets USFDA nod for cancer injectionDrug firm Strides Arcolab on Tuesday said its subsidiary has received approval from the US health regulator for the launch of Gemcitabine i...
- Strides Arcolab FY'10 net up 11.63 pc at Rs 122.44 crThe company's India brand business achieved Rs 47 crore in sales. In Africa, the company posted sales of $ 6.09 million and added four new ...
- Pfizer to cut 1,100 R&D jobsPfizer Inc says it will lay off more than 1,000 employees at its Groton, Connecticut, research and development site as the drug giant cuts ...
- Read succeeds Kindler as Pfizer CEOIan C Read has been appointed as President and Chief Executive Officer (CEO) of Pfizer Inc, the US-based drug maker, succeeding Jeffrey B K...
Load More
